Peer Review History

Original SubmissionAugust 19, 2020
Decision Letter - Jeremy Camp, Editor

Dear Mr. García-Carrasco,

Thank you very much for submitting your manuscript "Predicting the spatio-temporal spread of the West Nile virus in Europe" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.  

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript. 

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Jeremy Camp, Ph.D.

Deputy Editor

PLOS Neglected Tropical Diseases

Jeremy Camp

Deputy Editor

PLOS Neglected Tropical Diseases

***********************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: The objectives of the study are clear, the study design is appropriate to address the stated objectives.

analyses used in the study were correct to support the conclusions.

Reviewer #2: (No Response)

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: The results are clearly and completely presented.

Reviewer #2: (No Response)

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: Conclusions supported the presented data. Authors also discuss how these data can be helpful to predicts the locations of WNF outbreaks better (e.g.spatio-environmental model) and the environmental model predicts the intensity of the WNV cases.

Reviewer #2: (No Response)

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: Minor comments:

The influence of precipitation in the spring and early summer month would also be interesting to consider. The considered variables in the development of the models are annual precipitation and precipitation seasonality. Are they enough to get a good picture of the influence of precipitation? In addition, the influence of rain-fed agriculture on WNFV indicates, that this could be important to look into.

Reviewer #2: (No Response)

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: Manuscript ID: PNTD-D-20-1456

Title: Predicting the spatio-temporal spread of the West Nile virus in Europe

The manuscript describes the development of risk models for spread of one of the most important emerging arboviral infections in Europe. The spatio-environmental model predicts the locations of WNF outbreaks best, and the environmental model predicts the intensity of the cases. The information gained in the manuscript is in-line with the previous knowledge. An English lecturer should read the introduction.

Minor comments:

The influence of precipitation in the spring and early summer month would also be interesting to consider. The considered variables in the development of the models are annual precipitation and precipitation seasonality. Are they enough to get a good picture of the influence of precipitation? In addition, the influence of rain-fed agriculture on WNFV indicates, that this could be important to look into.

Reviewer #2: The manuscript “Predicting the spatio-temporal spread of the West Nile virus in Europe ” is an original work aiming to provide insights on how environmental variables can be exploited to predict the spread of WNV in Europe. The topic is of interest. However, the length of the manuscript renders it quite difficult to focus and uncover the most important things. Additionally, several parts of the text are lengthy and irrelevant to the study – e.g. the first paragraph of the introduction, other phrases within that section, etc. The discussion is also rather extended (9 pages) and requires its re-reading several times in order to extract the important findings of this work. I suggest that the authors rearrange their manuscript by keeping only the important parts of it.

Line 4. “West Nile virus” (and elsewhere in the manuscript).

Line 5. The term “final hosts” applies for parasites, wherein a “final” host is required to complete the biological cycle. The proper term here is “dead-end” or “incidental”.

Line 6. “Which affects the nervous system causing the West Nile Fever (WNF), leading to death”. a) The fact that the virus affects the nervous system (a condition called West Nile neuroinvasive disease, WNND) is not the same as fever. b) The way this has been written implies that WNV infection has always a lethal outcome. Please rephrase and use proper medical reports to present this sentence properly. This also applies for lines 31-32.

Lines 6-8. “Since the circulation of the virus in Europe in the 1950s, human cases have just increased, with 2018 having the highest number of cases registered to date”. The expression “human cases have just increased” is misleading, as “just” should refer to the last 25 years. The first large-scale epidemics in humans occurred in Romania during 1996, with 393 encephalitis cases in humans, including 16 deaths. Lineage 2 was first isolated in 2004 and increased numbers of cases due to this lineage were observed from 2010 onwards. This also applies for lines 32-33.

Lines 44-54. This paragraph is irrelevant to the present study. The introduction should briefly summarize the current situation as well as what is lacking from literature regarding the studied topic.

Line 55. “Flavivirus” and “Flaviviridae” should be italicized to comply with ICTV nomenclature rules.

Lines 60-61. Reference to non-existent vaccines and drugs is not associated with the study.

Lines 55-64. I suggest to reorganize and simplify this paragraph, by mentioning firstly how the virus is being transmitted, secondly the hosts, and lastly the condition in infected humans.

Lines 65-77. This paragraph is also lengthy. The authors should help the reader focus to the main targets of their work and introduction should be written in a way to assist to this process. The fact, for example, that WNV took its name by the West Nile district of Uganda is distracting, not to mention that it is widely known.

Line 119. “WNV-specific IgM”, etc. Use “serum (or virus) neutralization test” instead of “neutralization”.

Line 275. “Rain-fed agriculture, as well as poultry and horse livestock were the human activities that also contributed to explain the distribution of the WNF” How do the authors interpret the finding regarding horses? Other factors are directly associated with the vector or the propagation of the virus itself (birds). So, could there be an explanation or hypothesis for this finding?

Line 517. “Horse density also appears to favor the outbreak of the disease. This may be caused by the fact that equids are also dead-end hosts of the virus cycle.” How can this be supported? In horses the virus acts as in humans (dead-end) and mosquitoes cannot get infected by an infected horse. So, the dead-end character of the infection of horses (and humans), which is an accidental thing, is not expected to favor the outbreaks.

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see http://journals.plos.org/plosntds/s/submission-guidelines#loc-materials-and-methods

Revision 1

Attachments
Attachment
Submitted filename: Authors response.docx
Decision Letter - Jeremy Camp, Editor

Dear Mr. García-Carrasco,

Thank you very much for submitting your manuscript "Predicting the spatio-temporal spread of the West Nile virus in Europe" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

As mentioned previously, due to the Covid-19 pandemic, one first-round reviewer withdrew from the peer-review process. A third reviewer was invited and has provided a largely positive review with only a few minor suggestions for improvement. Thus, I would like to provide you with an opportunity to respond to the third reviewer's comments.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.  

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript. 

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Jeremy Camp, Ph.D.

Deputy Editor

PLOS Neglected Tropical Diseases

***********************

Reviewer's Responses to Questions

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #3: No

--------------------

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #3: The objectives of the study are clearly elaborated and developed based on several established hypotheses. To address them, a well-calculated design has been made with several appropriate approaches. Although the methodology presented is extensive, it makes this analysis easier to understand. The population used for the predictive analysis is clearly described, supported by solid databases, with a sufficient sample size so that, in short, it is appropriate for the hypothesis analyzed in this work.

The statistical analysis used is correct to support the conclusions.

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #3: The analysis presented is adjusted to the stated objectives, the results are clearly and completely presented, and the figures (tables, images) are of sufficient quality for clarity.

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #3: The limitations of the analysis are clearly described throughout. The conclusions are supported by the data presented, with a subsequent discussion that, although extensive, is well developed, with a good relationship between results and available data on the incidence of WNV and its causes, so it is useful to advance in the prediction of future outbreaks, both of this virus and of other possible zoonotic ones. This work is, therefore, highly relevant for public health.

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #3: Minor points:

- Delete the article in front of WNV and WNF throughout the entire document. Example: on line 4 replace "The West Nile virus ...." with "West Nile virus ....", on lines 46-47 replace "When infected by the WNV ...." with "When infected by WNV .... ", line 48 replace" that is known as the West Nile fever (WNF) "with" that is known as West Nile fever (WNF) ", or on line 312 replace" the WNF cases ..." by "WNF cases ... "

- line 8: better replace “in Europe” with “the continent” in order not to repeat “Europe” so many times.

- Replace throughout the document "the Julian week" by "the July week"

- line 33: “being 2018 the year with…”

- lines 60-62: (The transmission season of 2018 was exceptional; 1,605 cases were confirmed, which is twice as high as the sum of cases recorded in the previous three years): better “The transmission season of 2018 was exceptional; 1,605 cases were confirmed, which is double the sum of cases registered in the previous three years”

- line 72: “…are helpful for predicting the risk for WNF outbreaks” replace by “… are useful for predicting the risk of WNF outbreaks.”

- line 154: (“…added at each step if and only if the resulting new regression was…”) delete “if and”

- line 243: a comma is needed (“…the higher the spatial and environmental favorability, the earlier the cases would…”)

- lines 270, 285: delete “Error! Reference source not found.”

- line 424: change “Other studies also showed that the WNF incidence had a…” by “Other studies also showed that the incidence of WNF had a…”

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see http://journals.plos.org/plosntds/s/submission-guidelines#loc-materials-and-methods

Revision 2

Attachments
Attachment
Submitted filename: Authors response.docx
Decision Letter - Jeremy Camp, Editor

Dear Mr. García-Carrasco,

We are pleased to inform you that your manuscript 'Predicting the spatio-temporal spread of West Nile virus in Europe' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Jeremy Camp, Ph.D.

Deputy Editor

PLOS Neglected Tropical Diseases

Jeremy Camp

Deputy Editor

PLOS Neglected Tropical Diseases

***********************************************************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #3: (No Response)

**********

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #3: (No Response)

**********

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #3: (No Response)

**********

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #3: (No Response)

**********

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #3: (No Response)

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #3: No

Formally Accepted
Acceptance Letter - Jeremy Camp, Editor

Dear Mr. García-Carrasco,

We are delighted to inform you that your manuscript, "Predicting the spatio-temporal spread of West Nile virus in Europe," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .